LumiraDx to Announce Third Quarter 2021 Financial Results and Host Quarterly Conference Call on November 10

Rhea-AI Summary

LumiraDx (Nasdaq:LMDX) will announce its third quarter 2021 financial results on November 10, 2021. A conference call and webcast are scheduled for 8 AM ET to discuss the results and business highlights. The company specializes in next-generation point of care diagnostics, producing over 30 tests for various diseases. LumiraDx has a strong presence in community-based healthcare, deploying its solutions across multiple platforms. Investors can access a replay of the call on LumiraDx's investor website shortly after the event.

Positive

• LumiraDx is launching its Q3 2021 financial results, which may reflect positive financial health.
• The company has over 30 diagnostic tests on the market, indicating a diverse product offering.
• Deployment of testing solutions in various healthcare settings suggests strong demand.

Negative

• None.

LONDON, Nov. 2, 2021 /PRNewswire/ -- LumiraDx  (Nasdaq:LMDX), a next-generation point of care (POC) diagnostics company, announced it will release its third quarter 2021 financial results on Wednesday, November 10, 2021. On the day of the release, LumiraDx will host a conference call and webcast at 8 AM Eastern Time to review the financial results and business highlights.

Event:	LumiraDx Third Quarter 2021 Financial Results Conference Call
Date:	Wednesday, November 10, 2021
Time:	8:00 AM Eastern Time
Live Call/Webcast:	(844) 224-4100 (Domestic), (215) 372-9500 (International)
	Conference ID: 5184314
	https://investors.lumiradx.com/news-and-events/investor-calendar

A replay of the webcast will be available on the Investor's section of the company's website at investors.lumiradx.com shortly after the conclusion of the call. The webcast will be archived for 90 days.

About LumiraDx
LumiraDx (Nasdaq: LMDX) is a next-generation point of care diagnostics company that is transforming community-based healthcare. Founded in 2014, LumiraDx manufactures and commercializes an innovative diagnostic Platform that supports a broad menu of tests with lab comparable performance at the point of care. LumiraDx diagnostic testing solutions are being deployed by governments and leading healthcare institutions across laboratories, urgent care, physician offices, pharmacies, schools, and workplaces to screen, diagnose, and monitor wellness as well as disease. LumiraDx has, on the market and in development, 30+ tests covering infectious diseases, cardiovascular diseases, diabetes, and coagulation disorders, all on the LumiraDx Platform. In addition, LumiraDx has a comprehensive portfolio of fast, accurate, and cost-efficient COVID-19 testing solutions from the lab to point of need. LumiraDx is based in the UK with more than 1500 employees worldwide.

Further information on LumiraDx and the LumiraDx Platform is available at www.lumiradx.com

Contact:
Colleen McMillen
Colleen.McMillen@lumiradx.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/lumiradx-to-announce-third-quarter-2021-financial-results-and-host-quarterly-conference-call-on-november-10-301413950.html

SOURCE LumiraDx

FAQ

When will LumiraDx release its third quarter 2021 financial results?

LumiraDx will release its third quarter 2021 financial results on November 10, 2021.

What time is the LumiraDx conference call for financial results?

The conference call will be held at 8 AM Eastern Time on November 10, 2021.

How can I access the LumiraDx financial results conference call?

You can access the conference call via a webcast at the LumiraDx investor website.

What does LumiraDx specialize in?

LumiraDx specializes in next-generation point of care diagnostics with over 30 tests for various health conditions.

Where is LumiraDx based?

LumiraDx is based in the UK and employs over 1500 people globally.